FDA Approves ‘Game-Changing’ Pancreatic Cancer Drug
The FDA approved a daily pill called Rasonque, that in clinical trials doubled survival time for many patients compared to chemotherapy alone. NBC’s medical contributor Dr. Natalie Azar joins TODAY to break down how the drug impacts cancer treatment. “This particular medicine is targeting a protein that has eluded scientists for literally decades,” she says.
NBC News Health
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from NBC News Health.
In this story
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
All-time coverage
7 publications have covered this story since CurrentWire first saw it: NBC News Health, NPR, CBS News, NBC News, ABC News, France 24, STAT.
Coverage
1 publication is covering this story.
How coverage developed
Story updateNPR joined coverage
First report from NBC News Health
Story updateNBC News Health joined coverage
Story updateCoverage went from 5 to 4 sources
Story updateCoverage went from 4 to 2 sources
Story updateHeadline updated
Story updateCoverage went from 2 to 1 sources
How CurrentWire compiled this story
NBC News Health (www.today.com), a Tier C publisher, filed this report on . CurrentWire published this page on .
Signal breakdown
CurrentWire ranked this story 39.6 of 100 in the snapshot this page was rendered from.
- Freshness
- 6.6 of 35
- Source authority
- 9 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 10 of 10
- Story prominence
- 10 of 10
- Velocity
- 0 of 5
Strongest signal: geographic relevance, 10 of 10. How each signal is calculated.
Filed under Health · United States · News. Topics extracted from this report, with other live CurrentWire stories mentioning each: FDA (7), Game-Changing Pancreatic Cancer Drug (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.